Welcome to the News Room

Positioning Ireland as a global innovation leader in the 4th Industrial Revolution

Posted by:

Professor Pugatch delivered a keynote presentation at the 25th Annual Conference of the Irish Pharmaceutical Healthcare Association (IPHA) at Dublin, Ireland, themed ‘Patient Care, Powered By Innovation’.

In the field of professional boxing, Ireland was and remains a global superpower and a role model. Yet in the field of biopharmaceutical innovation, Ireland does not step into the ring of greats:

  • Despite retaining the reputation of a global leader in advances biopharmaceutical manufacturing – with €10 billion invested over the past decade – important opportunities for increasing local research capacity under Horizon 2020 and IMI were missed.
  • Ireland’s performance in global indices is mixed – high on employment impact, low on patenting rates and scientific outputs.
  • Clinical research levels remain low compared to Ireland’s potential, and corporate biopharma R&D investments follow suit.
  • The market access environment is challenging, with low levels of access to innovative treatments and long delays in reimbursement decisions.

Ireland can attain global leadership in both advanced bio-manufacturing as well as biotech innovation. This goal can be achieved by building confidence through constructive industry-government partnerships, enabling the continued public support in local innovative capacity while increasing attractiveness to biomedical FDI.

Looking to the Fourth Industrial Revolution, is it time for Ireland to put on the boxing gloves?

Prof. Pugatch’s presentation, and a snapshot of the IPHA’s 25th Annual Conference can be viewed

Ma'ayan Laufer

About the Author:

Ma’ayan Laufer is a senior consultant at Pugatch Consilium - a boutique consultancy that provides evidence-based research, analysis and intelligence on the fastest growing sectors of the knowledge economy. Ma’ayan specializes in regulatory and economic analysis related to healthcare, pharmaceuticals, intellectual property and innovation. He has wide experience in benchmarking excellence in the biomedical and pharmacovigilance fields, and specific experience in mapping clinical trial, registration and pharmacovigilance environments. Ma’ayan holds an MSc in Healthcare Management & Administration from the University of Haifa.
  Related Posts
  • No related posts found.